1. Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients.
- Author
-
Pinheiro SL, Maciel J, Cavaco D, Figueiredo AA, Damásio IL, Donato S, Passos J, and Simões-Pereira J
- Subjects
- Humans, Child, Male, Female, Follow-Up Studies, Retrospective Studies, Gonadotropin-Releasing Hormone, Neurofibromatosis 1 complications, Neurofibromatosis 1 diagnostic imaging, Optic Nerve Glioma complications, Optic Nerve Glioma diagnosis, Optic Nerve Glioma therapy, Optic Nerve Neoplasms complications, Puberty, Precocious etiology, Puberty, Precocious complications
- Abstract
Purpose: Central precocious puberty (CPP) in neurofibromatosis type 1 (NF1) occurs mainly in association with optic pathway glioma (OPG), but it can also develop in the absence of OPG. The aim of this study was to analyze the prevalence of puberty disorders in children with NF1 and its association with OPG and its location., Methods: A retrospective study of 45 children with NF1 (68.9% boys) followed at our center between 2008 and 2020 was conducted. A cerebral MRI scan was performed in all children. We analyzed auxological, laboratory, and imaging data of children with CPP or accelerated puberty (AP). Treatments used for CPP/AP and their effect on height were also evaluated., Results: The prevalence of puberty disorders in our cohort was 17.8% (male to female ratio of 7:1). CPP and AP were diagnosed in 8/45 (17.8%) NF1 children. Among children with puberty disorders, 5/8 (62.5%) had an OPG with chiasm involvement, 1/8 (12.5%) had an isolated optic nerve tumor, and 2/8 (25%) did not have any evidence of OPG on MRI. Fisher's exact test showed an association between CPP/AP and chiasm OPG (p = 0.025). Treatment with triptorrelin was initiated in 5/8 children, of whom four attained final predicted height., Conclusion: Our study confirms the higher prevalence of CPP/AP in NF1 patients, as well as an association between chiasm OPG and puberty disorders. However, CPP/AP also occurred in the absence of OPG with an incidence of 9.1%. Comprehensive evaluation of every child with NF1 regardless of the presence of OPG is therefore essential., (© 2022. The Author(s), under exclusive licence to Hellenic Endocrine Society.)
- Published
- 2023
- Full Text
- View/download PDF